C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.170
+0.220 (7.46%)
At close: May 11, 2026, 4:00 PM EDT
3.150
-0.020 (-0.63%)
Pre-market: May 12, 2026, 7:42 AM EDT
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or -5.45% compared to the previous year.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$345,644
Profits / Employee
-$1,009,558
Market Cap
349.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 104 | -6 | -5.45% |
| Dec 31, 2024 | 110 | -35 | -24.14% |
| Dec 31, 2023 | 145 | -1 | -0.68% |
| Dec 31, 2022 | 146 | 25 | 20.66% |
| Dec 31, 2021 | 121 | 22 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Puma Biotechnology | 179 |
| Neumora Therapeutics | 96 |
| Silence Therapeutics | 88 |
| Immuneering | 53 |
| Surrozen | 44 |
| Compass Therapeutics | 39 |
| DiaMedica Therapeutics | 35 |
CCCC News
- 51 minutes ago - C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion - Reuters
- 4 weeks ago - C4 Therapeutics expands long-term partnership with Roche - TheFly
- 4 weeks ago - C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) - GlobeNewsWire
- 6 weeks ago - C4 Therapeutics doses first patient in cemsidomide trial - TheFly
- 6 weeks ago - C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma - GlobeNewsWire
- 2 months ago - C4 Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire